Neoadjuvant therapy for breast cancer.
CONCLUSIONS: The use of NT in Italy is limited and variable. There are no signs of greater use in hospitals with more advanced care.
PMID: 31496430 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Hormonal Therapy | Hormones | Italy Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women